Print version of this report
Type of Product Medical Device
TGA Recall Reference RC-2024-RN-00480-1
Product Name/Description ClopineCENTRAL 2.0 - Pharmaceutical management support software

ARTG not on the register
Recall Action Level Hospital
Recall Action Classification Class II
Recall Action Commencement Date 17/06/2024
Responsible Entity Pfizer Australia Pty Ltd
Reason/Issue ClopineCENTRAL2,0: technical problems identified after deployment from 10 May 2024 in Australia included, but not limited to:
1. Inability for pharmacists to enter dispensing details for patients.
2. Notifications for all patients in the system (active/inactive) sent to HCPs, who get overwhelmed with emails, and are unable to identify those which need actioning, and those which are old.
3. Problems with permissions of users.
4. If users have not activated their account they cannot be selected within the system, as such other users cannot select them as active HCP involved in the patient’s care until they re-activate their account.
Recall Action Product Defect Correction
Recall Action Instructions Pfizer notes that these problems have been resolved as part of a software update. This software has been available to users who have registered since 10 May 2024.

If customers have questions regarding this Product Defect Correction, or any other general questions about the software update, they will need to contact Pfizer Medical Information, or alternatively the Clopine Services Team.
Contact Information 1800 675 229 - Pfizer Medical Information or 1800 656 403 - Clopine Services Team